Jiangsu Lianhuan Pharmaceutical Co., Ltd. (SHSE: 600513)
Health Care · Pharmaceuticals · CN
CN¥16.64
-5.56% today · -34.3% 1Y
Jiangsu Lianhuan Pharmaceutical Co., Ltd. (SHSE: 600513) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $706.59M and employs 2,131 people.
Over the last twelve months the share price has lost 34.3%, trading between 13.67 and 32.27.
Tweenvest scores Jiangsu Lianhuan Pharmaceutical Co., Ltd. across four factors: quality 60/100, value 28/100, growth 55/100, dividend 22/100. Its strongest factor is quality.
600513 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $706.59M
- Revenue (TTM)
- $419.69M
- P/E
- —
- EPS
- -0.39
- Dividend yield
- 0.42%
- Beta (5Y)
- -0.22
- 52-week high
- CN¥32.27
- 52-week low
- CN¥13.67
- Avg volume (3M)
- —
- Shares outstanding
- 285.46M
- Employees
- 2,131
- Next earnings
- —
About Jiangsu Lianhuan Pharmaceutical Co., Ltd.
Jiangsu Lianhuan Pharmaceutical Co., Ltd. operates within China, specializing in the production and distribution of chemical raw materials, pharmaceutical formulations, and organic intermediate compounds. Its extensive product range addresses diverse therapeutic needs, including cardiovascular issues, allergies, urinary tract conditions, infectious diseases, and immune system modulation. The enterprise was founded in 2000 and has its principal headquarters located in Yangzhou, China.
- ISIN
- CNE000001DP6
- Founded
- 1999
- Listed since
- Mar 19, 2003
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,189.41 | -3.59% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $270.00 | -1.15% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.10 | -2.14% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.30 | -0.95% |
Figures last refreshed Aug 18, 2026.